Assessment of Individuals With Older Age Bipolar Disorder


Between 1980 and 1998, the relative frequency of late-onset bipolar disorder increased from 1% to 11%. How can you best assess for this condition?



The DSM-5 describes bipolar disorder (BD) as a condition that is characterized by recurrent and/or cyclical episodes of mania or hypomania and depression.1 In the DSM-5, there are 2 subtypes of BD: bipolar I disorder (BD-I) and bipolar II disorder (BD-II). A diagnosis of BD-I is established if an individual experiences at least 1 manic episode with additional major depressive and/or hypomanic episodes. Individuals are diagnosed with BD-II if they experience at least 1 hypomanic episode and at least 1 major depressive episode without any manic episodes. Although BD is not as common among older adults as it is among younger adults, available evidence indicates that the total number of older adults with BD is expected to increase significantly over the next few decades.2,3 It has been observed that between 1980 and 1998, the relative frequency of late-onset bipolar disorder increased from 1% to 11%.4

According to the International Society for Bipolar Disorders (ISBD) Task Force, “older age bipolar disorder” (OABD) is defined as BD occurring in individuals ≥ 50 years of age.5One quarter of all cases of BD occur among individuals ≥ 60 years of age and > 10% of the cases occurred among individuals ≥ 70 years of age.6

OABD has a point prevalence of 0.1% to 0.5% and a lifetime prevalence of 0.5% to 1.0%.7 Among older adults who are diagnosed with a mood disorder, 10% to 25% have BD.8,9 New-onset mania later in life occurs in approximately 10% of individuals with OABD, and it is often associated with neurovascular disease.3 Among older adults who go to the emergency room for a psychiatric evaluation, BD has been noted in 17% of cases.8 Approximately 8% to 10% of geriatric inpatient admissions and 6% of geriatric psychiatry outpatient visits include individuals with OABD. Among individuals who live in residential psychiatric program for older adults, the prevalence of bipolar disorder is approximately 17.4%.8 A diagnosis of BD is noted in approximately 3% of older nursing home residents and 9.7% of older chronically institutionalized individuals. Approximately 70% of individuals with OABD are women.8

Comparison Between OABD and Early-Onset Bipolar Disorder

Individuals with OABD often present with depression rather than hypomania or mania as the presenting symptom.10-12 They also tend have more frequent recurrences of depressive episodes and present with symptoms that are severe.13 In contrast to individuals with early-onset bipolar disorder (EOBD), individuals with OABD present with greater latency periods between the initial and subsequent mood episodes.11 There is also significantly less family history of mood disorders noted among individuals with OABD when compared to individuals with EOBD.10,14 These individuals also have a history of more stressful life events when compared to age-matched controls.15

Individuals with OABD also present with more comorbid conditions including cardiovascular, respiratory, endocrine, and metabolic disorders.16-19 These individuals often present with an average of 3 to 4 comorbid medical conditions.20 These comorbid conditions also worsen outcomes for individuals with OAD, including the risk for suicide.18,19

When compared to individuals with EOBD, individuals with OABD often present with greater association with cerebrovascular disease and other neurological disorders.7 They often present with increased white-matter hyperintensities in frontal, parietal, and putaminal brain areas.21-23 Individuals with OABD may have greater cortical sulcal widening and lateral ventricle-brain ratio scores when compared to individuals with EOBD.24,25 On neuroimaging studies, these individuals present with greater morphological abnormalities of the brain when compared to individuals with EOBD.26 It has also been noted that among individuals with OABD, depressive symptoms are often associated with left cerebral hemisphere vascular lesions, whereas manic symptoms are often associated with right cerebral hemisphere vascular changes.26,27

Available evidence indicates that when compared to age-matched controls, psychiatric comorbidities are more common among individuals with OABD, but the rates of these comorbidities are lower than what is seen among individuals with EOAD.23 Alcohol use disorder is the most common comorbid psychiatric disorder among individuals with OABD, with a 12-month and a lifetime prevalence of 38.1% and 38.1%, respectively.28 The other common psychiatric comorbidities are (12-month and lifetime prevalence rates): panic disorder (11.9% and 19.0%), generalized anxiety disorder (9.5% and 20.5%), and dysthymia (7.1% and 15.5%). It has been noted that older women with OABD have a greater prevalence of panic disorder when compared to age-matched controls, whereas older men have a greater prevalence of alcoholism.28 Available evidence indicates that the prevalence rates for psychotic symptoms among individuals with OABD are similar to those of individuals with EOBD.8 When compared to individuals with EOBD, the risk for suicide among individuals with OABD appears to be lower.5

When compared to age-matched controls, varying degrees of cognitive impairment have been identified among a majority of individuals with OABD.29 These include lower Mattis Dementia Rating Scale (DRS) scores (P=0.0003) and Mini-Mental State Examination (MMSE) scores (P=0.0007). When compared to individuals with EOBD, about half of individuals with OABD score ≥ 1 standard deviation (SD) below the mean on the DRS and MMSE total scores.30 However, no correlation has been noted between the Young Mania Rating Scale (YMRS) scores and the cognitive functioning among these individuals.29 Available evidence indicates that individuals with OABD also present with worse psychomotor functioning and mental flexibility when compared to individuals with EOBD.31 Greater cognitive impairment has been noted among individuals with OABD who have more vascular risk factors and a greater number of hospitalizations.32

Table. Differences Between EOBD and OABD

Table. Differences Between EOBD and OABD

When compared to age-matched individuals with unipolar depression, individuals with OABD have an earlier age at onset of illness.33 They are also noted to have higher total symptom severity, to have higher positive symptom scores, and to be more impaired in community living skills.33 When compared to aged-matched controls, these individuals are also 4 times more likely to use mental health services and 4 times more likely to have psychiatric hospitalizations. The Table describes the difference between EOBD and OABD.34


It is imperative to obtain a detailed history when assessing individuals with OABD.34 This history will also help identify individuals who develop mood symptoms due to secondary medical and/or neurological disorders. Additionally, individuals who develop mood swings due to the effects of prescribed drugs or drugs of abuse can be identified by obtaining a thorough history. Comorbid medical and/or neurological disorders can be identified by a focused physical examination. Laboratory workup can also identify common conditions that cause mood symptoms, including hyperthyroidism.34 Laboratory workup that is commonly ordered as a screening tool among individuals with OABD include a complete blood count, a complete metabolic panel, a thyroid panel, urine-analysis and culture, and drug screen. Additional tests that can be ordered include vitamin B12 and folate levels, rapid plasma regain/Venereal Disease Research Laboratory test, and human immunodeficiency virus (HIV) testing if nutritional deficiency, neurosyphilis, or HIV infections are suspected as possible comorbid conditions. If cerebrovascular disease is suspected as a possible etiology for mood symptoms or there is evidence of cognitive dysfunction among individuals with OABD, computerized tomography or magnetic resonance imaging scans can be obtained.34

Figure. Process for Diagnosing OABD

Figure. Process for Diagnosing OABD

Although there are no specific screening tools for the diagnosis of OABD, some available instruments can assist with quantifying and qualifying the symptoms of OABD and in monitoring their progress. The Mood Disorder Questionnaire is a common screening tool that has been identified as having good sensitivity and specificity for detecting a lifetime history of mania or hypomania, although the potential for over-diagnosis of BD is a known limitation for this screening instrument.35,36 Other screening instruments include the Bipolar Spectrum Diagnostic Scale, the Hypomanic Personality Scale, the Bipolar Depression Rating Scale, and the YMRS.38-40 The most widely used clinical assessment tool for the diagnosis of bipolar disorder is the structured clinical interview from the DSM-IV.37 After the screening process, the DSM-5 criteria can assist with confirming the diagnosis of BD.1 The Figure describes the process for diagnosing OABD.34

Concluding Thoughts

Available evidence indicates that OABD is not an uncommon condition. Individuals with OABD present with less family history of psychiatric disorders but greater burden of medical comorbidities when compared to individuals with EOBD. When compared to age-matched controls, these individuals have higher rates of health care service utilization and worse outcomes. It is imperative to rule out underlying medical disorders, adverse effects of prescribed medications, and/or the adverse effects of drugs of abuse as possible etiologies for OABD.

Dr Tampi is professor and chairman of the Department of Psychiatry at Creighton University School of Medicine and Catholic Health Initiatives (CHI) Health Behavioral Health Services in Omaha, Nebraska. He is also an adjunct professor of psychiatry at Yale School of Medicine. Ms Tampi is cofounder and managing principal of Behavioral Health Advisory Group in Princeton, New Jersey.


1. Bipolar disorders. Desk Reference to the Diagnostic Criteria From DSM-5. American Psychiatric Publishing; 2013:65-92.

2. Montes JM, Alegria A, Garcia-Lopez A, et al. Understanding bipolar disorder in late life. J Nerv Ment Dis. 2013;201(8):674-679.

3. Dols A, Beekman A. Older age bipolar disorder. Clin Geriatr Med. 2020;36(2):281-296.

4. Almeida OP, Fenner S. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int Psychogeriatr. 2002;14(3):311-322.

5. Sajatovic M, Strejilevich SA, Gildengers AG, et al. A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disord. 2015;17(7):689-704.

6. Sajatovic M, Blow FC, Ignacio RV, Kales HC. Age-related modifiers of clinical presentation and health service use among veterans with bipolar disorder. Psychiatr Serv. 2004;55(9):1014-1021.

7. Sajatovic M, Chen P. Geriatric bipolar disorder. Psychiatr Clin North Am. 2011;34(2):319-333.

8. Depp CA, Jin H, Mohamed S, et al. Bipolar disorder in middle-aged and elderly adults: is age of onset important? J Nerv Ment Dis. 2004;192(11):796-799.

9. Yassa R, Nair V, Nastase C, et al. Prevalence of bipolar disorder in a psychogeriatric population. J Affect Disord. 1988;14(3):197-201.

10. Stone K. Mania in the elderly. Br J Psychiatry. 1989;155:220-224.

11. Shulman KI, Tohen M, Satlin A, et al. Mania compared with unipolar depression in old age. Am J Psychiatry. 1992;149(3):341-345.

12. Tohen M, Shulman KI, Satlin A. First-episode mania in late life. Am J Psychiatry. 1994;151(1):130-132.

13. García-López A, Ezquiaga E, De Dios C, Agud JL. Depressive symptoms in early- and late-onset older bipolar patients compared with younger ones. Int J Geriatr Psychiatry. 2017;32(2):201-207.

14. Hays JC, Krishnan KR, George LK, Blazer DG. Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. Depress Anxiety. 1998;7(2):76-82.

15. Beyer JL, Kuchibhatla M, Cassidy F, Krishnan KR. Stressful life events in older bipolar patients. Int J Geriatr Psychiatry. 2008;23(12):1271-1275.

16. Gildengers AG, Whyte EM, Drayer RA, et al. Medical burden in late-life bipolar and major depressive disorders. Am J Geriatr Psychiatry. 2008;16(3):194-200.

17. Kilbourne AM, Post EP, Nossek A, et al. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Psychiatr Serv. 2008;59(7):760-768.

18. McIntyre RS, Konarski JZ, Soczynska JK, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv. 2006;57(8):1140-1144.

19. Juurlink DN, Herrmann N, Szalai JP, et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004;164(11):1179-1184.

20. Lala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol. 2012;25(1):20-25.

21. Subramaniam H, Dennis MS, Byrne EJ. The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry. 2007;22(8):733-737.

22. Lloyd AJ, Moore PB, Cousins DA, et al. White matter lesions in euthymic patients with bipolar disorder. Acta Psychiatr Scand. 2009;120(6):481-491.

23. Tamashiro JH, Zung S, Zanetti MV, et al. Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord. 2008;10(7):765-775.

24. Sarnicola A, Kempton M, Germanà C, et al. No differential effect of age on brain matter volume and cognition in bipolar patients and healthy individuals. Bipolar Disord. 2009;11(3):316-322.

25. Young RC, Nambudiri DE, Jain H, et al. Brain computed tomography in geriatric manic disorder. Biol Psychiatry. 1999;45(8):1063-1065.

26. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry. 1998;43(10):705-712.

27. Robinson RG, Starkstein SE. Current research in affective disorders following stroke. J Neuropsychiatry Clin Neurosci. 1990;2(1):1-14.

28. Goldstein BI, Herrmann N, Shulman KI. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. Am J Psychiatry. 2006;163(2):319-321.

29. Young RC, Murphy CF, Heo M, et al. Cognitive impairment in bipolar disorder in old age: literature review and findings in manic patients. Affect Disord. 2006;92(1):125-131.

30. Gildengers AG, Butters MA, Seligman K, et al. Cognitive functioning in late-life bipolar disorder. Am J Psychiatry. 2004;161(4):736-738.

31. Schouws SN, Comijs HC, Dekker J, et al. Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry. 2009;17(6):508-515.

32. Schouws SN, Stek ML, Comijs HC, et al. Risk factors for cognitive impairment in elderly bipolar patients. J Affect Disord. 2010;125(1-3):330-335.

33. Bartels SJ, Forester B, Miles KM, et al. Mental health service use by elderly patients with bipolar disorder and unipolar major depression. Am J Geriatr Psychiatry. 2000;8(2):160-166.

34. Tampi RR, Joshi P, Bhattacharya G, Gupta S. Evaluation and treatment of older-age bipolar disorder: a narrative review. Drugs Context. 2021;10:2021-1-8.

35. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873-1875.

36. Zimmerman M, Ruggero CJ, Galione JN, et al. Detecting differences in diagnostic assessment of bipolar disorder. J Nerv Ment Dis. 2010;198(5):339-342.

37. Baldassano CF. Assessment tools for screening and monitoring bipolar disorder. Bipolar Disord. 2005;7 Suppl 1:8-15.

38. Picardi A. Rating scales in bipolar disorder. Curr Opin Psychiatry. 2009;22(1):42-49.

39. Berk M, Malhi GS, Cahill C, et al. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disord. 2007;9(6):571-579.

40. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435.

Related Videos
Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?
© 2024 MJH Life Sciences

All rights reserved.